Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06260345

CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit

Severe bacterial infections are a worldwide scourge. However, the epidemiology of this type of infection varies over time. It is therefore essential to monitor them in order to prevent them more effectively. At this time, in France, no monitoring exists for this kind of infections.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Hospitalized Children Infections Invasive Bacterial Infection Severe Infection

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

The main aim of this study is to assess the number of cases and describe the clinical, biological and microbiological characteristics of these cases of severe communautary invasive bacterial infections in children hospitalized in pediatric intensive care units. In addition, the management of these hospitalized children will be described.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age <18 years (only hospitalized children)
  • Severe communautary bacterial infection defined by hospitalization in a pediatric intensive care unit (documentation of infection by identification of the bacteria in a sterile environment).

Exclusion criteria

  • Refusal by one of the parents or by Child in understanding age
  • Nosocomial infection

Treatment and study plan

Primary outcomes

  1. number of pediatrics cases of severe communautary bacterial infections

    Time frame: 1 year

    Proportion of hospitalized children in intensive care unit due to severe communautary bacterial infections

  2. medical characterisation of children hospitalized for severe communautary bacterial infection case

    Time frame: 1 year

    Assessment of clinical, biological and microbiological characteristics of hospitalized children in intensive care unit due to severe communautary bacterial infections cases

Secondary outcomes

  1. Identify risk factors of serious infection

    Time frame: 1 year

    Describe what is responsible of serious infection

  2. Identify predictive signs of severe cases in infected children.

    Time frame: 1 year

    what are the warning signs of a serious infection?

  3. healthcare used for infected children

    Time frame: 1 year

    Describe healthcare provided during hospitalisation of infected children in order to manage this type of infection

  4. Type of complications

    Time frame: 1 year

    Describe any complications due to infection

  5. Patients outcome

    Time frame: 1 year

    Proportion of patients recovered

  6. treatment used during hospitalisation

    Time frame: 1 year

    type of treatment used during hospitalisation to manage the infection

  7. Bacterial strain characterization

    Time frame: 1 year

    What bacterial strain is involved in the infection

Study contacts

Contact information is provided by the study sponsor or research team.

Corinne Levy

CONTACT

[email protected]

1 48 85 04 04 ext. +33

stéphane Béchet

CONTACT

[email protected]

1 48 85 04 04 ext. +33

Sponsors and collaborators

Lead sponsor

Association Clinique Thérapeutique Infantile du val de Marne

Other

Collaborators

  • Centre National de Référence des E. Coli
  • Centre National de Référence des Méningocoques et Haemophilus influenzae
  • Centre National de Référence des Pneumocoques
  • Centre National de Référence des Streptocoques
  • Centre National de Référence des staphylocoques
  • GFRUP (Groupe Francophone de Réanimation et d'Urgences Pédiatrique)
  • Groupe de Pathologies Infectieuses Pédiatriques (GPIP)

Registry information

Official study title

Observatory of Pediatric Severe Communautary Bacterial Infections

Acronym: CAPRICE

Important dates

Study start
2024
Primary completion
2030
Study completion
2030
First posted
Feb 15, 2024
Registry last updated
Mar 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.